-
From Being Targeted to Launching a Counterattack: BeiGene's Patent Battle in International Markets
In the ever-evolving landscape of the pharmaceutical industry, the pursuit of patents has become a critical aspect of competition for drug companies.
2024-03-19 15:57 -
Exclusive Overseas Authorization for Two Biologics: BIO-THERA Strikes a $6 Million Deal
BIO-THERA Pharmaceuticals, a leading biopharmaceutical company, has recently announced a major milestone in its global expansion strategy.
2024-03-19 15:55 -
New RadioMedicine Technology Raises Over 300 Million Yuan in Series C Funding
New RadioMedicine Technology, a leading healthcare company specializing in the research, development, and industrialization of radiopharmaceuticals, h...
2024-03-19 15:48 -
Breakthrough Biotech Company Contineum Therapeutics Files for IPO, Securing $150 Million Funding
Contineum Therapeutics, a leading biotechnology company based in the United States, has recently submitted its Initial Public Offering (IPO) applicati...
2024-03-19 15:46 -
WuXi AppTec Achieves Record-breaking Revenue of 40.34 Billion Yuan in 2023
WuXi AppTec, a leading pharmaceutical company, has announced its impressive financial results for the year 2023. With remarkable growth in revenue and...
2024-03-19 15:40 -
Peptides: The Ultimate Beneficiaries of Technological Iteration, Disrupting the Market Landscape
Peptides have emerged as a revolutionary force in the field of pharmaceuticals, consistently gaining recognition in clinical settings and experiencing...
2024-03-19 15:36 -
Biotech Companies BIO-THERA and SteinCares Sign Licensing and Commercialization Agreement for Two In...
BIO-THERA and SteinCares, two prominent biotech companies, have recently entered into a significant licensing and commercialization agreement worth $6...
2024-03-19 15:26 -
Breakthrough Clinical Data on Nectin-4 ADC Targeted Therapy for Cervical Cancer Revealed
Mabwell Biotechnology unveiled groundbreaking clinical data on their targeted therapy, Nectin-4 ADC, for the treatment of cervical cancer.
2024-03-18 11:47 -
CanSino Biologics and AsymBio Collaborate to Harness mRNA Technology
In a recent strategic partnership, CanSino Biologics (Shanghai) Biotechnology Co., Ltd. and Shanghai AsymBio Biotechnology Co., Ltd. have joined force...
2024-03-18 11:44 -
Breakthrough Treatment for Incurable Breast Cancer Receives Official Acceptance by Chinese Drug Admi...
"TROP 2 ADC" has achieved formal acceptance by the China Drug Administration (CDE) for the treatment of advanced breast cancer.
2024-03-18 11:42
Hot News
- BASF’s Big Restructuring: Cut... Sep 01, 2025
- DuPont Bids Farewell to Its Ar... Sep 02, 2025
- Glenmark Recalls Over 110000 B... Aug 24, 2025
- FDA Clears Sanofi’s Wayrilz (... Aug 31, 2025
- Wanhua Chemical Boosts TDI Cap... Aug 24, 2025
Related Products
Related Producers
